We value your privacy
This site uses cookies to improve your browsing experience, analyze site traffic, and show personalized content.
Omipalisib + Doxycycline. Highly promising longevity cocktail, shown to more than double the lifespan of worms with an unprecedented 109% median lifespan extension. Potent mTOR inhibitor combined with an FDA-approved antibiotic with dose-dependent anti-inflammatory effects. Represents a bold bet on synergistic mechanisms to push the boundaries of lifespan extension. Launched by Rapamycin Longevity Lab in collaboration with the Center for Healthy Longevity, National University of Singapore.
| $70.37% | |
| $40.18% | |
| $20.09% | |
| $0.710.04% | |
| $0.680.03% | |
| $0.470.02% | |
| $0.180.01% | |
| $0.100.00% | |
| $0.060.00% |